Andersen ML et al. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol 91.2-3 (2004): 325-30.
Argento AE et al. Oral anticoagulants and medicinal plants: An emerging interaction. Ann Ital Med Intern 15.2 (2000): 139-43.
Betancor-Fernandez A et al. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 55.7 (2003): 981-6.
Blumenthal M, Goldberg A, Brinckmann J (eds). Herbal Medicine: Expanded Commission E Monographs. Austin, TX: Integrative Medicine Communications, 2000.
Boje K, Lechtenberg M, Nährstedt A. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 69 (2003): 820-5.
Bone K, Walker M. Devil's claw. MediHerb Professional Review. Australia: Mediherb Pty Ltd (February 1997).
Chantre P et al. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 7.3 (2000): 177-83.
Chrubasik JE et al. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine (2006) [Epub ahead of print].
Chrubasik S. Devil's claw extract as an example of the effectiveness of herbal analgesics. Der Orthopäde 33.7 (2004a): 804-8.
Chrubasik S. Salix and Harpagophytum for chronic joint and low back pain: From evidence-based view herbal medicinal products are recommended. Schweiz Z GanzheitsMed 16.6 (2004b): 355-9.
Chrubasik S et al. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 3.1 (1996): 1-10.
Chrubasik S et al. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind study. Eur J Anaesthesiol 16.2 (1999): 118-29.
Chrubasik S et al. Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hip. Phytomedicine 9.3 (2002): 181-94.
Chrubasik S et al. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 10.6-7 (2003a): 613-23.
Chrubasik S et al. A randomized double-blind pilot study comparing Doloteffm(R) and Vioxx(R) in the treatment of low back pain. Rheumatology 42.1 (2003b): 141-8.
Chrubasik S et al. A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology 42.1 (2003c): 141-8.
Chrubasik S et al. A 1-year follow-up after a pilot study with Doloteffm(R) for low back pain. Phytomedicine 12.1-2 (2005): 1-9.
Clarkson C et al. In vitro antiplasmodial activity of abietane and totarane diterpenes isolated from Harpagophytum procumbens (Devil's Claw). Planta Med 69.8 (2003): 720-4.
European Scientific Co-operative On Phytomedicine (ESCOP), 2nd edn. Stuttgart: Thieme, 2003.
Fetrow CW, Avila JR. Professionals' Handbook of Complementary and Alternative Medicines. Springhouse, PA: Springhouse Publishing, 1999.
Fiebich BL et al. Inhibition of TNF-alpha synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 8.1 (2001): 28-30.
Fisher C, Painter G. Materia Medica for the Southern hemisphere. Auckland: Fisher-Painter Publishers, 1996.
Gagnier JJ et al. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med 4 (2004): 13.
Gobel HA et al. Effects of Harpagophytum procumbens LI 174 (devil's claw) on sensory, motor and vascular muscle reagibility in the treatment of unspecific back pain. Schmerz 15.1 (2001): 10-18.
Heck AM et al. Potential interactions between alternative therapies and warfarin. Am J Health-System Pharm 57.13 (2000): 1221-7; quiz 1228-30.
Huang TH et al. Harpagoside suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kappaB activation. J Ethnopharmacol 104 (2006): 149-55.
Jang MH et al. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sei 93.3 (2003): 367-71.
Kaszkin M et al. Downregulation of iNOS expression in rat mesangial cells by special extracts of
Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 11.7-8 (2004a): 585-95.
Kaszkin M et al. High dosed Harpagophytum special extract for maintenance of remission in patients with Crohn's disease: A case report. Arztezeitschr Natur heil verfahr 45.2 (2004b): 102-6.
Kundu JK et al. Inhibitory effects of the extracts of Sutherlandia frutescens (L.) R. Br. and Harpagophytum procumbens DC. on phorbol ester-induced COX-2 expression in mouse skin: AP-1 and CREB as potential upstream targets. Cancer Lett 218.1 (2005): 21-31.
Langmead L et al. Antioxidant effects of herbal therapies used by patients with inflammatory bowel disease: an in vitro study. Aliment Pharmacol Ther 16.2 (2002): 197-205.
Laudahn D, Walper A. Efficacy and tolerance of Harpagophytum extract LI 174 in patients with chronic non-radicular back pain. Phytother Res 15.7 (2001): 621-4.
Leblan D, Chantre P, Four nie B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis: Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 67.5 (2000): 462-7.
Loew D et al. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 69.5 (2001): 356-64.
Mahomed IM, Ojewole JAO. Analgesic, antiinflammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res 18.12 (2004): 982-9.
McGregor GB et al. Devil's claw (Harpagophytum procumbens): An anti-inflammatory herb with therapeutic potential. Phytochem Rev 4.1 (2005): 47-53.
Mills S, Bone K. Principles and Practice of Phytotherapy. London: Churchill Livingstone, 2000.
Moussard CD et al. A drug used in traditional medicine, Harpagophytum procumbens: no evidence for NSAID-like effect on whole blood eicosanoid production in human. Prostaglandins Leukot Essent Fatty Acids 46.4 (1992): 283-6.
Na HK et al. Inhibition of phorbol ester-induced COX-2 expression by some edible African plants. BioFactors (Oxford) 21.1-4 (2004): 149-53.
Newell CA, Anderson LA, Phillipson JD. Herbal medicines: A Guide for Health Care Professionals. London, UK: The Pharmaceutical Press, 1996.
Schmidt A et al. Effectiveness of Harpagophytum procumbens in treatment of unspecific low back pain. Physikal Med Rehabilitationsmed Kurortmed 15.5 (2005): 317-21.
Schulze-Tanzil G, Hansen C, Shakibaei M. Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung 54 (2004): 213-20.
Soulimani R et al. The role of stomachal digestion on the pharmacological activity of plant extracts, using as an Devil's claw JJO
example extracts of Harpagophytum procumbens. Can J Physiol Pharmacol 72.12 (1994): 1532-6.
Stewart KM, Cole D. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: The devil's in the details. J Ethnopharmacol 100.3 (2005): 225-36.
Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun in Mass Spectrometry 18.19 (2004): 2273-81.
Van Wyk BE, Gericke N. People's Plants: A Guide to Useful Plants of Southern Africa. Pretoria: Briza Publications, 2000.
Wegener T, Lupke N-P. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC). Phytother Res 17.10 (2003): 1165-72.
Whitehouse LW et al. Devil's claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 129.3 (1983): 249-51.
Was this article helpful?